U.S. Markets closed

Organogenesis: 3Q Earnings Snapshot

·1 min read

CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Monday reported third-quarter net income of $20.9 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Canton, Massachusetts-based company said it had net income of 19 cents.

The regenerative medicine company posted revenue of $100.8 million in the period.

Organogenesis expects full-year revenue in the range of $311 million to $314 million.

In the final minutes of trading on Monday, the company's shares hit $4.15. A year ago, they were trading at $7.24.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO